Study on the Incidence of Adrenal Insufficiency After Surgery in Primary Aldosteronism Patients Concurrent With or Without Autonomous Cortisol Secretion
Recruiting
Observational Study
Primary Aldosteronism
Autonomous Cortisol Secretion
Adrenal Insufficiency
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 70
- Sex
- Any
- Study type
- Observational
- Participants needed
- 521 (estimated)
- Sponsor
- Qifu Li · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
To evaluate the incidence of adrenal insufficiency after surgery in Primary aldosteronism (PA) patients concurrent with or without autonomous cortisol secretion (ACS). To assess the recovery time of postoperative adrenal insufficiency in patients. And to explore the clinical characteristics and predictive indicators of patients requiring postoperative hormone replacement therapy.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
* A confirmed diagnosis of primary aldosteronism or autonomous cortisol secretion;
② Completion of unilateral adrenal surgery;
③ Voluntary participation and obtaining informed consent. (2) Exclusion criteria
* Patients with typical clinical manifestations of Cushing's syndrome;
* Patients s…
Contacts